ALZpath
Carlsbad, US · Delaware corporation · 10 employees on LinkedIn
Alzpath develops diagnostic tools for early and accurate detection of Alzheimer's disease. The company serves clinicians and patients seeking improved diagnostic accuracy and accessibility across the care pathway.
Founders & leadership
MB
Michael BanvilleNamed on SEC filing
Board
IR
Irit RappleyBoard director
JS
Jerre SteadBoard director
HJ
Harry JohnsBoard director
JC
John CourtneyBoard director
JH
John HensingBoard director
SB
Samantha Budd HaeberleinBoard director
Reported raises · per SEC filings
Form D private placements$8.4M disclosed across 1 round · 2026
▶$8.4MraisedJul 2026 · 8 investors · BiotechnologyRule 506(b)
▶$8.4MraisedJul 2026 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael BanvilleExecutive Officer, Promoter
- Jerre SteadDirector
- Harry JohnsDirector
- John CourtneyDirector
- John HensingDirector
- Irit RappleyDirector
- Samantha Budd HaeberleinDirector
- Offering amount
- $10.4M
- Amount sold
- $8.4M
- Finders' fees
- $125K
- Placement agents
- AEG Capital, LLC
- First sale
- Jul 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp24 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.
Quest Diagnostics21 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Quanterix18 shared keywordsQuanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention. The company serves the precision healthcare and life sciences research market with biomarker detection tools.
Companies competing with ALZpath for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does ALZpath do?
- Alzpath develops diagnostic tools for early and accurate detection of Alzheimer's disease. The company serves clinicians and patients seeking improved diagnostic accuracy and accessibility across the care pathway.
- How much funding has ALZpath raised?
- ALZpath has disclosed $8.4M raised across 1 round.
- Where is ALZpath headquartered?
- ALZpath is headquartered in Carlsbad, US.